Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
Carl E StafstromSection of Pediatric Neurology, Departments of Neurology and Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USAObjective: This review summarizes the treatment of Lennox-Gastaut syndrome, an intractable epileptic encephalopathy of e...
Main Author: | Carl E Stafstrom |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/update-on-the-management-of-lennox-gastaut-syndrome-with-a-focus-on-ru-a3664 |
Similar Items
-
Rufinamide in patients with Lennox-Gastaut syndrome
by: Clark PO, et al.
Published: (2016-11-01) -
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT
by: N. K. Mazina, et al.
Published: (2016-04-01) -
RUFINAMIDE IN THE TREATMENT OF LENNOX–GASTAUT SYNDROME: REVIEW OF FOREIGN LITERATURE
by: K. Yu. Mukhin, et al.
Published: (2015-06-01) -
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
by: Balagura G, et al.
Published: (2020-02-01) -
Rufinamide (inovelon) in the treatment of Lennox–gastaut syndrome (a review of literature)
by: К. Yu. Мukhin, et al.
Published: (2018-11-01)